Sadik Shaik

Sadik Shaik

Auto-generated profile, based on publicly available information

Sadik Shaik

Department of Pharmacology Anuradha College of Pharmacy Bengaluru India

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 November 2025 in Food Science & Nutrition
Verified
Journal Article
Open access
Shankar ThapaShankar Thapa
Shankar Thapa
DPDeepti Pandey
Deepti Pandey
MBMahalakshmi Suresha Biradar
Mahalakshmi Suresha Biradar
MAMonica Arora
Monica Arora
SVShithin Ann Varghese
Shithin Ann Varghese
BPBipindra Pandey
Bipindra Pandey
Diabetes is among the top ten causes of mortality and morbidity. Diabetes has been increasing faster in low‐ and middle‐income nations than it has been rising in high‐income countries. This study explores the phytochemical profiling and in vitro α‐amylase inhibitory activity of the methanolic extract of Nepalese‐origin pomegranate peels. Phytochemical analysis using FT‐IR and LC–MS identified key bioactive compounds, including ellagic acid, punicalagin, punicalin, gallic acid, and ellagic acid‐O‐xylopyranoside, contributing to the observed enzymatic inhibition. Molecular docking studies revealed strong binding affinities of punicalagin (−11.6 kcal/mol) and ellagic acid‐O‐xylopyranoside (−10.6 kcal/mol) to α‐amylase, suggesting potential antidiabetic properties. MD simulations confirmed the stability of these interactions over a 100 ns timeframe, reinforcing their role in enzyme inhibition. The in vitro α‐amylase inhibition assay demonstrated comparable activity of pomegranate peel extract (IC 50 = 137.74 μg/mL) to reference drug acarbose (IC 50 = 222.19 μg/mL). These findings provide molecular insights into the bioactivity of pomegranate peel extracts, highlighting their potential in diabetes management.

26 May 2021 in Research Journal of Pharmacy and Technology
Verified
Journal Article
Closed access
GMGurram Lakshmana Murthy
Gurram Lakshmana Murthy
VTVasia Tamreen
Vasia Tamreen
CCChandrika C.
Chandrika C.
SIShazia Iryn
Shazia Iryn
SMSuchitra M
Suchitra M
SSShaik Sadik
Shaik Sadik
The main of the research work to develop sustained release floating matrix tablets of ATZ, which were designed to extend the gastric residence time and prolong the drug release after oral administration. Different grades of polymers such as EC and HPMC K100M were used in order to get the desired floating and sustained release profile over prolonged period of time. All the formulations extended the drug release up to 24 hours and more and the formulations were optimized for the desired release profiles. The release and floating property was depends on the polymer type and polymer proportion. The formulation prepared with Ethyl cellulose and HPMC K100M has more floating time than the formulation prepared with the Ethyl cellulose alone. The FTIR study shows that there is no drug-polymer interaction. This study gives the preliminary idea about the development of the floating drug delivery systems of Atazanavir without the use of gas generating agent.

12 January 2026 in Bioinformatics and Biology Insights
Verified
Journal Article
Open access
KKKeshava Ks
Keshava Ks
FIFaten Qais Ibraheem
Faten Qais Ibraheem
Shankar ThapaShankar Thapa
Shankar Thapa
SMSomashekhar M Metri
Somashekhar M Metri
SSSadik Shaik
Sadik Shaik
PTPramila T
Pramila T
Proviral Integration site for Moloney murine leukemia virus-1 (PIM-1) kinase, a serine/threonine kinase overexpressed in various malignancies, plays a critical role in promoting cell survival and proliferation, making it a promising target for anticancer therapy. This study employed an integrated in silico approach to evaluate Lepiotaprocerin derivatives (A to L) from Macrolepiota procera as potential PIM-1 inhibitors. Molecular docking of 12 Lepiotaprocerins revealed Lepiotaprocerin C as the most potent compound, exhibiting superior binding affinity (−11.4 kcal/mol) compared with the reference inhibitor AZD1208. Binding site validation using CASTp, PrankWeb, and blind docking confirmed the ATP-binding pocket as the active cavity. The Lepiotaprocerin C-PIM-1 complex demonstrated enhanced stability during 200 ns molecular dynamics simulations, maintaining low RMSD and strong hydrogen-bond interactions, supported by a favorable Molecular Mechanics/Poisson-Boltzmann Surface Area (MM/PBSA) binding free energy (−22.0 ± 2.1 kcal/mol). Based on quantitative structure activity relationship (QSAR) analysis, the calculated pIC 50 value of Lepiotaprocerin C was 8.67. QSAR modeling ( R 2 = .74, Q 2 = 0.90) confirmed robust predictive capacity, while absorption, distribution, metabolism, and elimination and PerMM analysis indicated favorable pharmacokinetic and permeability profiles. Prediction of Activity Spectra for Substances and toxicity predictions further revealed high antineoplastic potential (Pa = 0.881) and a nontoxic safety profile. These results highlight Lepiotaprocerin C as a promising, stable, and safe inhibitor of PIM-1 kinase, warranting further in vitro and in vivo validation for potential anticancer drug development.

8 December 2025 in Natural Product Communications
Verified
Journal Article
Open access
KMKavya Manjunath
Kavya Manjunath
FFFady Habib Fayek
Fady Habib Fayek
SSShaik Sadik
Shaik Sadik
SNSreeharsha Nagaraja
Sreeharsha Nagaraja
SKSantosh Prasad Chaudhary Kurmi
Santosh Prasad Chaudhary Kurmi
Shankar ThapaShankar Thapa
Shankar Thapa
Background: Colorectal cancer (CRC) is a leading cause of cancer-related mortality worldwide. Statins, widely prescribed lipid-lowering agents, have been suggested to possess anticancer activity; however, their precise mechanisms in CRC remain poorly defined. Methods: This study employed an integrated in silico–in vitro approach to investigate the therapeutic potential of Simvastatin and Lovastatin in CRC. Network pharmacology analysis identified hub genes linking the mevalonate pathway, lipid biosynthesis, and apoptosis regulation. Molecular docking was performed to assess binding affinities, followed by molecular dynamics (MD) simulations and MM-PBSA free energy calculations for stability and binding strength evaluation. In vitro cytotoxicity was validated using HCT116 and HT-29 colorectal cancer cell lines. Results: Five hub genes (HMGCR, CYP51A1, FDFT1, SCD, and LCK) were identified as key targets. Docking studies revealed strong binding affinities, with scores of −8.4 kcal·mol −1 for Simvastatin–3LCK, −9.5 kcal·mol −1 for Lovastatin–3WEG, and −9.4 kcal·mol −1 for Lovastatin–8SBI complexes. MD simulations indicated stable binding of Simvastatin with 3LCK, characterized by minimal RMSD and SASA fluctuations, whereas Lovastatin displayed higher flexibility. MM-PBSA analysis demonstrated robust binding free energies for Lovastatin–3WEG (–64.73 kcal·mol −1 ) and Simvastatin–3LCK (–56.47 kcal·mol −1 ). In vitro assays confirmed a dose-dependent reduction in cell viability, with IC 50 values of 8.9 ± 0.17 μM (Simvastatin) and 12.6 ± 0.32 μM (Lovastatin) in HCT116, compared with 14.4 ± 0.15 μM and 18.7 ± 0.53 μM in HT-29 cells, respectively. Conclusion: This integrated study demonstrates that Simvastatin and Lovastatin exert cytotoxic effects in CRC cells by targeting metabolic and apoptotic pathways. Simvastatin showed superior activity compared with Lovastatin.

6 July 2026 in RSC Advances
Verified
Journal Article
Open access
STSundarrajan Thirugnanasambandam
Sundarrajan Thirugnanasambandam
NBNeerugatti Dora Babu
Neerugatti Dora Babu
ANAnitha K N
Anitha K N
SSSadik Shaik
Sadik Shaik
SMShankar M
Shankar M
Shankar ThapaShankar Thapa
Shankar Thapa
The rapid emergence of antimicrobial resistance demands the discovery of new antibacterial targets and inhibitors. Staphylococcus aureus filamenting temperature-sensitive protein (SaFtsZ), an essential cytoskeletal protein involved in bacterial cytokinesis and Z-ring formation, has gained attention as a promising target for antibacterial drug discovery. In the present study, an integrated computational strategy involving pharmacophore mapping, molecular docking, molecular dynamics (MD) simulations, and density functional theory (DFT) analysis was employed to identify potential SaFtsZ inhibitors. Initially, large compound library was screened from the Pharmit database using a structure-based pharmacophore model to identify molecules with key interaction features required for SaFtsZ inhibition. The selected 200 candidates were further evaluated through molecular docking to determine their binding affinity and interaction pattern within the active site of SaFtsZ. Among the screened molecules, compound 15 (CID 135468497) exhibited the highest binding affinity with a docking score of -10.8 kcal mol-1. Subsequent MD simulation confirmed the stability of the protein-ligand complex, while DFT analysis provided insights into the electronic characteristics and reactivity of compound 15. These findings highlight compound 15 as a computationally predicted scaffold for the development of SaFtsZ-targeted antibacterial agents. However, experimental validation is required to confirm the computational results.

29 October 2025 in Current Bioactive Compounds
Verified
Journal Article
Closed access
PDF file
SSShaik Sadik
Shaik Sadik
VTVasia Tamreen
Vasia Tamreen
MTMuthukumaran Thulasingam
Muthukumaran Thulasingam
LNLaxmesh Narasimhamurthy
Laxmesh Narasimhamurthy
SJSandipan Jana
Sandipan Jana
ASArik Nabi Shah
Arik Nabi Shah
Introduction: Silver nanoparticles (AgNPs) have been widely studied for their antioxidant and anticancer properties. Vernonia cinerea has demonstrated significant antitumor activity, particularly in inhibiting the growth of colorectal cancer cells. This study aims to synthesize silver nanoparticles using Vernonia cinerea leaf extract and evaluate their antioxidant and anticancer efficacy against colorectal cancer cell lines. Methods: AgNPs were synthesized via the combustion method using Vernonia cinerea leaf extract. The nanoparticles were characterized for their physico-chemical and morphological properties using Fourier Transform Infrared Spectroscopy (FTIR), Scanning Electron Microscopy (SEM), UV-visible spectrophotometry (UV-Vis), and X-Ray Diffraction (XRD) analysis. Antioxidant activity was assessed using the DPPH assay, and anticancer potential was evaluated through cytotoxicity assays on CaCo2 colorectal cancer cells using varying concentrations of AgNO₀. Results: FTIR analysis revealed characteristic absorption bands at 664, 605, 557, 531, and 513 cm⁸¹, confirming the formation of silver ion-bound nanoparticles. XRD analysis showed Bragg’s reflections at 38.066°, 31.59°, 37.56°, 53.01°, 64.93°, and 76.27°, indicating crystalline structure. Elemental analysis confirmed a 60% silver ion composition. The synthesized AgNPs exhibited dose-dependent antioxidant activity and significant cytotoxic effects against CaCo2 cells. Discussion: The incorporation of Vernonia cinerea extract into AgNPs enhanced the stability and biological activity of the nanoparticles. The observed anticancer effects support previous findings on the therapeutic potential of both AgNPs and Vernonia cinerea. Limitations include the need for in vivo studies to confirm these results. result: The absorption bands at 664 cm-1, 605 cm-1, 557 cm-1, 531 cm-1, and 513 cm-1 in the FTIR range of Vernonia Cinerea (VC) AgNP’s demonstrated the formation of silver ion-bounded nanoparticles of the VC extract. These results indicate that AgNP’s coated with Vernonia have several characteristics that enhance their stability. The diffraction of the X-ray spectrum of the produced AgNP’s showed the Braggs reflections in the XRD pattern 38.066, 31.59, 37.56, 53.01, 64.93, and 76.27. The sample's elemental composition was determined through elemental analysis, with 60% silver ions. After conducting antioxidant investigations on AgNP concentrations using the DPPH assay, the study conducted a cell-based cytotoxic experiment using different doses of AgNO3. Conclusion: Synthesized silver nanoparticles using Vernonia cinerea exhibit strong antioxidant activity and significant anticancer effects, reducing CaCo2 cell proliferation and motility. These findings support their potential as therapeutic agents in the treatment of colorectal cancer.